Investigating oral antiviral treatments for COVID-19 in high-risk patients
Oral Antivirals against COVID-19 and Clinical Outcomes in High Risk Populations
This study is looking at how well two oral antiviral medications, Nirmatrelvir/ritonavir and Molnupiravir, work to treat COVID-19 in people who are at higher risk of getting very sick, so we can better understand how to help them recover.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Foundation NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10886497 on NIH RePORTER |
What this research studies
This research focuses on evaluating the effectiveness of two oral antiviral medications, Nirmatrelvir/ritonavir and Molnupiravir, in treating COVID-19 among high-risk populations. The study aims to gather real-world data on how these treatments perform in preventing severe disease and improving clinical outcomes. By analyzing patient responses and outcomes, the research seeks to provide valuable insights that can guide treatment decisions for vulnerable groups. The findings will help ensure that these antiviral agents are used appropriately based on solid clinical evidence.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at high risk for severe COVID-19, such as those with underlying health conditions or older adults.
Not a fit: Patients who are not at high risk for severe COVID-19 or those who have already received effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols for high-risk patients with COVID-19, potentially reducing hospitalizations and severe outcomes.
How similar studies have performed: Other research has shown promising results with similar antiviral treatments for COVID-19, indicating potential for success in this investigation.
Where this research is happening
Pittsburgh, United States
- Veterans Health Foundation — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Butt, Adeel a — Veterans Health Foundation
- Study coordinator: Butt, Adeel a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.